BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Somatic Cell Gene Editing - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Somatic Cell Gene Editing
X-ORIGINAL-URL:https://scge.mcw.edu
X-WR-CALDESC:Events for Somatic Cell Gene Editing
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20260308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20261101T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240920T073000
DTEND;TZID=America/Chicago:20240920T173000
DTSTAMP:20260418T091809
CREATED:20240710T134050Z
LAST-MODIFIED:20240710T134155Z
UID:4307-1726817400-1726853400@scge.mcw.edu
SUMMARY:The Safe and Effective Practice of AAV Gene Therapy
DESCRIPTION:Join the Clinical In Vivo Gene Therapy (CIGT) team at Children’s Hospital of Philadelphia for an exciting one-day educational symposium\, as we provide fundamental knowledge on the safe and effective practice of adeno-associated virus (AAV) gene therapy across medical specialties. SCGE researchers Lindsey George\, Beverly Davidson\, and Rebecca Ahrens-Nicklas are scheduled to be speaking at the event. \nFriday September 20\, 2024 || Philadelphia\, PA \nView the registration info here
URL:https://scge.mcw.edu/events/the-safe-and-effective-practice-of-aav-gene-therapy/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/07/Screenshot-2024-07-10-083625.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240920T100000
DTEND;TZID=America/Chicago:20240920T153000
DTSTAMP:20260418T091809
CREATED:20240723T134352Z
LAST-MODIFIED:20240723T134352Z
UID:4333-1726826400-1726846200@scge.mcw.edu
SUMMARY:Meeting 1: Patient and Care Partner Perspectives on Safety Considerations for Approved Gene Therapy Treatments for Rare Diseases
DESCRIPTION:The FDA Center for Biologics Evaluation and Research (CBER) is hosting a public patient listening meeting and opening a docket to better understand patient and care partner perspectives on safety considerations and long-term follow-up for approved gene therapy treatments for rare diseases. \nThe objectives of this listening meeting are to hear from patients and care partners on their perspectives on short-term and long-term risks of approved gene therapy products\, to learn what types of information patients would find helpful in their decision-making when considering gene therapy\, to learn about their considerations and experience with participating in long-term studies after receiving a gene therapy\, and to help inform patient-centered protocols for long-term studies that include gene therapy outcomes.  The meeting will be divided into two sessions. \nRegister for the Zoom meeting here: https://web.cvent.com/event/0b2da86e-f7d1-4288-9d11-2cb9cabe87c5/regProcessStep \nRegistration will close on Thursday\, September 19\, 2024\, at 11:59 pm ET. A recording and other relevant meeting materials will be posted online following the event.
URL:https://scge.mcw.edu/events/meeting-1-patient-and-care-partner-perspectives-on-safety-considerations-for-approved-gene-therapy-treatments-for-rare-diseases/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/07/Screenshot-2024-07-23-084318.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240923
DTEND;VALUE=DATE:20240925
DTSTAMP:20260418T091809
CREATED:20240820T162113Z
LAST-MODIFIED:20240820T162211Z
UID:4435-1727049600-1727222399@scge.mcw.edu
SUMMARY:2024 Policy Summit
DESCRIPTION:The 2024 Policy Summit will include experts on topics such as global regulatory harmonization\, clinical development challenges\, the payment policy landscape\, CGT investment insights\, and more. Join other cell and gene therapy professionals at this 1.5-day event to learn about public policies and regulatory trends impacting the field. \nWashington DC/Hybrid \nRegister at https://www.asgct.org/advocacy/events-and-opportunities/policy-summit/registration \n 
URL:https://scge.mcw.edu/events/2024-policy-summit/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/08/ASGCT-policy-summit.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240924
DTEND;VALUE=DATE:20240927
DTSTAMP:20260418T091809
CREATED:20240808T145035Z
LAST-MODIFIED:20240808T145035Z
UID:4365-1727136000-1727395199@scge.mcw.edu
SUMMARY:3rd Annual Lipid Nanoparticles Development Summit Europe
DESCRIPTION:The 3rd Lipid Nanoparticles Development Summit Europe is your premier forum to collaborate with a carefully curated community of experts across Discovery\, Characterisation\, Translatability\, Formulation\, Biodistribution\, Manufacturing and much more. These industry leaders are gathering in Berlin this September to bring the greatest challenges in LNP development to the fore\, tackling them head on to ensure 2024 is the year of the LNP. \nBerlin\, Germany \nLearn more at: https://lipid-nanoparticle-development-europe.com/ 
URL:https://scge.mcw.edu/events/3rd-annual-lipid-nanoparticles-development-summit-europe/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/08/Screenshot-2024-08-08-095000.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240925
DTEND;VALUE=DATE:20240929
DTSTAMP:20260418T091809
CREATED:20240102T191519Z
LAST-MODIFIED:20240102T192205Z
UID:3427-1727222400-1727567999@scge.mcw.edu
SUMMARY:Week in RARE
DESCRIPTION:Week in RARE\, presented by Global Genes\, features the RARE Health Equity Forum and the RARE Advocacy Summit. \nThe RARE Health Equity Forum convenes stakeholders in the rare disease space to identify ways in which we can better serve marginalized populations within the rare disease community. In its third year\, the event will be focused on the theme of “Equity In Action”. \nThe RARE Advocacy Summit provides the opportunity to forge meaningful connections with others in the rare disease community for future collaboration. Sessions provide attendees with insights about the latest in rare disease innovations\, best practices for advocating on an individual and organizational level\, and actionable strategies they can take home and implement immediately to accelerate change. \nFind more information at: https://www.globalgenes.org/week-in-rare/
URL:https://scge.mcw.edu/events/rare-health-equity-forum/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/01/gg-logo-400x172_globalgenes.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240925
DTEND;VALUE=DATE:20240928
DTSTAMP:20260418T091809
CREATED:20240711T170555Z
LAST-MODIFIED:20240711T170555Z
UID:4318-1727222400-1727481599@scge.mcw.edu
SUMMARY:RESI Boston 2024
DESCRIPTION:The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain\, connecting start-ups with 10 categories of global investors across the silos of drugs\, devices\, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups\, those seeking grants\, seed and angel capital\, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare. \n9/25 – Boston \n9/26 and 9/27 – Virtual \nhttps://resiconference.com/ 
URL:https://scge.mcw.edu/events/resi-boston-2024/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/07/Screenshot-2024-07-11-120532.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241014
DTEND;VALUE=DATE:20241017
DTSTAMP:20260418T091809
CREATED:20240612T155954Z
LAST-MODIFIED:20240612T155954Z
UID:4294-1728864000-1729123199@scge.mcw.edu
SUMMARY:7th International Conference on CRISPR Technologies
DESCRIPTION:CRISPR 2024 is an exclusive conference that unites leaders from industry\, government agencies\, and academia to discuss the latest advancements in genome editing technologies. The program brings together experts from diverse fields to discuss how to safely and effectively translate these cutting-edge technologies to patients\, while remaining mindful of the ethical implications. \nSan Diego\, CA
URL:https://scge.mcw.edu/events/7th-international-conference-on-crispr-technologies/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/06/Screenshot-2024-06-12-105925.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241016
DTEND;VALUE=DATE:20241018
DTSTAMP:20260418T091809
CREATED:20240612T155628Z
LAST-MODIFIED:20240612T155628Z
UID:4292-1729036800-1729209599@scge.mcw.edu
SUMMARY:Advancing Gene and Cell Therapies for Cancer
DESCRIPTION:During this conference\, experts in the field will share their insights on targeting cancer-specific antigens\, highlight rational combinations to further enhance the function of CAR engineered cells\, describe ground-breaking efforts to engineer CAR engineered cells directly in vivo\, and illuminate the biology and risks of viral vector integration. \nPhiladelphia\, PA and Virtual
URL:https://scge.mcw.edu/events/advancing-gene-and-cell-therapies-for-cancer/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/06/Screenshot-2024-06-12-103632.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241016
DTEND;VALUE=DATE:20241018
DTSTAMP:20260418T091809
CREATED:20241014T135948Z
LAST-MODIFIED:20241014T140258Z
UID:4571-1729036800-1729209599@scge.mcw.edu
SUMMARY:2024 STAT Summit
DESCRIPTION:By gathering real operators from the trenches who have not previously spoken out\, not just talking heads\, this event covers some of the biggest challenges faced by those who want to move advances out of the lab and into the world. They will discuss everything from drug development and technology invention to dealing with regulators\, courting investors\, and pricing and selling products. \nHear from SCGE Phase 2 researchers Sonia Vallabh and Allyson Berent at this event! Sonia presents at 12:05pm ET on 10/16\, and Allyson presents at 3:45pm ET on 10/17. \nFind more info at: https://www.statnews.com/2024/summit/2024-stat-summit-2/ \nBoston\, MA or Virtual
URL:https://scge.mcw.edu/events/2024-stat-summit/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/10/Screenshot-2024-10-14-085854.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20241016T090000
DTEND;TZID=America/Chicago:20241016T133000
DTSTAMP:20260418T091809
CREATED:20241010T143855Z
LAST-MODIFIED:20241010T144012Z
UID:4567-1729069200-1729085400@scge.mcw.edu
SUMMARY:Advancing Rare Disease Therapies Through an FDA Rare Disease Innovation Hub
DESCRIPTION:The Reagan-Udall Foundation for the FDA\, in collaboration with FDA’s Rare Disease Innovation Hub\, will host a public meeting on October 16\, 2024. The meeting will bring together rare disease patient advocates\, academic researchers\, regulated industry\, and other key stakeholders to discuss how the recently announced Rare Disease Innovation Hub can best engage with members of the rare disease community and prioritize its work. \nHybrid Public Meeting: In-Person and Virtual \nOctober 16\, 2024 | 10am-2:30pm ET \nRegister at: https://reaganudall.org/news-and-events/events/advancing-rare-disease-therapies-through-an-fda-rare-disease-innovation-hub
URL:https://scge.mcw.edu/events/advancing-rare-disease-therapies-through-an-fda-rare-disease-innovation-hub/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/10/Screenshot-2024-10-10-093752.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241022
DTEND;VALUE=DATE:20241026
DTSTAMP:20260418T091809
CREATED:20240612T155327Z
LAST-MODIFIED:20240612T155327Z
UID:4289-1729555200-1729900799@scge.mcw.edu
SUMMARY:World Orphan Drug Congress Europe
DESCRIPTION:The World Orphan Drug Congress is the largest and most established orphan drugs & rare diseases meeting of its kind across the globe. \nBarcelona\, Spain
URL:https://scge.mcw.edu/events/world-orphan-drug-congress-europe/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/06/Screenshot-2024-06-12-105300.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241030
DTEND;VALUE=DATE:20241102
DTSTAMP:20260418T091809
CREATED:20240808T144734Z
LAST-MODIFIED:20240808T144734Z
UID:4362-1730246400-1730505599@scge.mcw.edu
SUMMARY:6th Annual Gene Therapy Analytical Development & CMC Summit
DESCRIPTION:The 6th Gene Therapy Analytical Development & CMC Summit will unite 250+ analytical development\, CMC\, QC\, and process development experts to showcase innovative analytical and process development methods\, assess their readiness\, and ultimately guarantee safety\, quality\, efficacy\, and consistency of gene therapies to regulators. \n\nBoston\, MA \nLearn more at https://www.genetherapy-analytical-cmc.com/
URL:https://scge.mcw.edu/events/6th-annual-gene-therapy-analytical-development-cmc-summit/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/08/Screenshot-2024-08-08-094701.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241119
DTEND;VALUE=DATE:20241121
DTSTAMP:20260418T091809
CREATED:20240820T162523Z
LAST-MODIFIED:20240820T162523Z
UID:4439-1731974400-1732147199@scge.mcw.edu
SUMMARY:Breakthroughs in Muscular Dystrophy
DESCRIPTION:Join ASGCT and the Muscular Dystrophy Association in downtown Chicago for an unparalleled opportunity to delve into the latest advancements in research on gene and cell therapies for muscular dystrophy. This 1.5-day event will bring together leading researchers and clinicians from the neuromuscular disease community to explore cutting-edge gene and cell therapies and technologies for muscular dystrophy. \nChicago\, IL \nhttps://www.asgct.org/events/breakthroughs-in-muscular-dystrophy/registration
URL:https://scge.mcw.edu/events/breakthroughs-in-muscular-dystrophy/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/08/Screenshot-2024-08-20-112456.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20241120T080000
DTEND;TZID=America/Chicago:20241120T150000
DTSTAMP:20260418T091809
CREATED:20241029T213601Z
LAST-MODIFIED:20241029T213601Z
UID:4634-1732089600-1732114800@scge.mcw.edu
SUMMARY:FDA Scientific Exchange 2024: Advancing Gene Editing Platforms for Rare Diseases
DESCRIPTION:On November 20th\, ISCT\, ARM\, and Danaher will convene key stakeholders to explore how to advance gene editing platforms. This Scientific Exchange with the FDA seeks to make progress on therapeutic development for rare conditions that are scientifically feasible but commercially non-viable. The Exchange will review case studies from academics and industry developers focused on gene editing\, with the objective of defining repeatable platforms that streamline development and regulatory requirements across multiple therapies for rare populations. Successful platforms hold promise to deliver faster and broader patient access to novel gene therapies while maintaining favorable risk-benefit balance and appropriate regulatory rigor. The attached background materials provide additional context. \nThe event will be live-streamed. \nRegister at https://www.isctglobal.org/event/fda-scientific-exchange-2024
URL:https://scge.mcw.edu/events/fda-scientific-exchange-2024-advancing-gene-editing-platforms-for-rare-diseases/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/10/Screenshot-2024-10-29-163510.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20241122T120000
DTEND;TZID=America/Chicago:20241122T124500
DTSTAMP:20260418T091809
CREATED:20241022T150033Z
LAST-MODIFIED:20241022T150033Z
UID:4597-1732276800-1732279500@scge.mcw.edu
SUMMARY:Real-World Evidence Webinar Series: Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice
DESCRIPTION:The Reagan-Udall Foundation for the FDA\, in collaboration with the Food and Drug Administration (FDA)\, is hosting a public webinar as part of a series of webinars for FDA-issued guidance related to real-world evidence (RWE). This latest session in the webinar series will discuss the draft guidance: Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice. \nThe guidance document addresses randomized controlled trials (RCTs) that have been integrated within routine clinical practice. Such RCTs have streamlined protocols that focus on collection of essential data and are often referred to as point-of-care or large\, simple trials. The guidance document discusses how leveraging established health care institutions can help reduce startup time and support trial enrollment. Involving local health care providers also offers convenience and accessibility to diverse patient populations who may not otherwise have the opportunity to participate. \nRegister at https://reaganudall.org/news-and-events/events/real-world-evidence-webinar-series-integrating-randomized-controlled-trials
URL:https://scge.mcw.edu/events/real-world-evidence-webinar-series-integrating-randomized-controlled-trials-for-drug-and-biological-products-into-routine-clinical-practice/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/10/Screenshot-2024-10-22-095942.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20250122T080000
DTEND;TZID=America/Chicago:20250123T120000
DTSTAMP:20260418T091809
CREATED:20241111T160743Z
LAST-MODIFIED:20241111T160743Z
UID:4654-1737532800-1737633600@scge.mcw.edu
SUMMARY:Class Considerations on Immunogenicity for AAV Gene Therapy Products: Assessing Current Practice and New Data
DESCRIPTION:ASGCT and FDA will host a virtual scientific workshop over two half days. This free\, public event will explore key immunology-related topics that have implications across the class of AAV gene therapies\, including immune responses\, antibody testing\, and redosing strategies. The workshop will provide valuable insights for professionals in both academia and industry as it addresses pressing challenges in AAV gene therapies and new approaches. \nRegister at: https://www.asgct.org/asgct-events/january-2025/class-considerations-on-immunogenicity-for-aav-gen \n 
URL:https://scge.mcw.edu/events/class-considerations-on-immunogenicity-for-aav-gene-therapy-products-assessing-current-practice-and-new-data/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/11/Screenshot-2024-11-11-100705.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250128
DTEND;VALUE=DATE:20250131
DTSTAMP:20260418T091809
CREATED:20240612T152939Z
LAST-MODIFIED:20240612T152939Z
UID:4271-1738022400-1738281599@scge.mcw.edu
SUMMARY:WCBP Symposium
DESCRIPTION:Stay tuned for more details.\n\nThe Mayflower Hotel in Washington D.C.\, United States.\n\nhttps://www.casss.org/meetings-and-events/event/2025/01/28/default-calendar/wcbp-2025
URL:https://scge.mcw.edu/events/wcbp-symposium/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/06/Screenshot-2024-06-12-102903.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250129
DTEND;VALUE=DATE:20250131
DTSTAMP:20260418T091809
CREATED:20240808T145616Z
LAST-MODIFIED:20240808T145616Z
UID:4371-1738108800-1738281599@scge.mcw.edu
SUMMARY:The Festival of Genomics & Biodata London
DESCRIPTION:With well over 5\,000 attendees the Festival is now the UK’s largest annual life sciences event. Thanks to the support of many people and organisations\, the Festival has become the annual get-together for the UK genomics community. It’s also expanded to cover so much more than genomics\, including biodata\, diagnostics\, drug discovery\, AI\, proteomics\, multi-omics and single-cell & spatial analysis. \nLondon\, UK \nLearn more at https://festivalofgenomics.com/london/en/page/home
URL:https://scge.mcw.edu/events/the-festival-of-genomics-biodata-london/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/08/Screenshot-2024-08-08-095536.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250227
DTEND;VALUE=DATE:20250301
DTSTAMP:20260418T091809
CREATED:20250113T143455Z
LAST-MODIFIED:20250113T143455Z
UID:4696-1740614400-1740787199@scge.mcw.edu
SUMMARY:FDA-NIH Rare Disease Day 2025
DESCRIPTION:This year\, NCATS and the U.S. Food and Drug Administration (FDA) will sponsor a shared Rare Disease Day event as part of this global observance. FDA-NIH Rare Disease Day aims to provide the rare disease community — patients\, caregivers\, families\, patient advocate groups\, researchers\, clinicians\, health care providers\, and trainees/students —with information relevant to their lived experiences\, including activities by FDA and NIH that promote research and product development for this underserved population. \nVirtual and In-Person \nMore info: https://ncats.nih.gov/news-events/events/rdd
URL:https://scge.mcw.edu/events/fda-nih-rare-disease-day-2025/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2025/01/Screenshot-2025-01-13-083150.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250312
DTEND;VALUE=DATE:20250314
DTSTAMP:20260418T091809
CREATED:20250128T151521Z
LAST-MODIFIED:20250128T151634Z
UID:4737-1741737600-1741910399@scge.mcw.edu
SUMMARY:Empowering Patients 2025
DESCRIPTION:This inaugural virtual event March 12 and 13\, 2025 (9 a.m. – 12:30 p.m. ET on both days)\, will provide timely education and engaging discussions on cell and gene therapies (CGTs). In alignment with ASGCT’s strategic plan\, the goal is to empower advocates\, patients\, and caregivers who are vital in developing treatments. Attendees will hear from experts in the CGT field\, as well as patient advocacy group leaders. There will be opportunities to ask questions and deepen your knowledge of the community’s CGT journey. \nVirtual \nhttps://www.asgct.org/asgct-events/march-2025/empowering-patients-2025-a-cell-and-gene-therapie
URL:https://scge.mcw.edu/events/empowering-patients-2025/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/06/Screenshot-2024-06-12-103632.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250318
DTEND;VALUE=DATE:20250320
DTSTAMP:20260418T091809
CREATED:20240808T150532Z
LAST-MODIFIED:20240808T150532Z
UID:4380-1742256000-1742428799@scge.mcw.edu
SUMMARY:Advanced Therapies 2025
DESCRIPTION:The Advanced Therapies Congress is Europe’s largest commerical cell and gene therapy conference and exhibition. The event is for the leaders of pioneering ATMP companies and their most senior executives in charge of the latest tech and strategies that are driving the industry forward. In 2025\, we’ll be bringing our community of 2\,500 global executives back together once again at London’s ExCel\, to be inspired by 300 speakers and 100 start-ups over 2 incredible days. The Advanced Therapies Congress features speakers from across the entire value chain of cell and gene therapy development; forward-thinking pharma\, biotech and start-up companies\, researchers\, clinicians\, academics\, HTAs\, payers and regulators. \nExCel\, London\, UK \nLearn more at https://www.terrapinn.com/congress/advanced-therapies/index.stm
URL:https://scge.mcw.edu/events/advanced-therapies-2025/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/08/Screenshot-2024-08-08-100423.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250318
DTEND;VALUE=DATE:20250321
DTSTAMP:20260418T091809
CREATED:20250128T155055Z
LAST-MODIFIED:20250128T155055Z
UID:4742-1742256000-1742515199@scge.mcw.edu
SUMMARY:Rare Disease Summit 2025
DESCRIPTION:The Rare Disease Summit connects key stakeholders to drive therapeutic progress\, propel commercial strategies and inspire impactful advocacy. You’ll generate solution-focused approaches surrounding patient access\, reimbursement\, commercialization\, launch\, partnering and more\, as you unify in areas of unmet medical need. \nPhiladelphia\, PA \nhttps://informaconnect.com/rare-disease-summit/
URL:https://scge.mcw.edu/events/rare-disease-summit-2025/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2025/01/Screenshot-2025-01-28-092407.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250325
DTEND;VALUE=DATE:20250328
DTSTAMP:20260418T091809
CREATED:20241111T161044Z
LAST-MODIFIED:20241111T161044Z
UID:4657-1742860800-1743119999@scge.mcw.edu
SUMMARY:8th Gene Therapy Development Summit
DESCRIPTION:Join peers to drive gene therapy innovation across translational\, clinical\, regulatory\, and manufacturing tracks. This event is designed to help attendees navigate the entire gene therapy pipeline. By refining gene delivery platforms\, optimizing manufacturing processes\, and navigating regulatory pathways\, we can revolutionize the future of gene therapies—bringing them to broader patient populations and significantly enhancing clinical outcomes. \nhttps://genetherapy-conference.com/ \nBoston\, MA
URL:https://scge.mcw.edu/events/8th-gene-therapy-development-summit/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/11/Screenshot-2024-11-11-101018.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250407
DTEND;VALUE=DATE:20250412
DTSTAMP:20260418T091809
CREATED:20240612T152546Z
LAST-MODIFIED:20240612T152546Z
UID:4268-1743984000-1744415999@scge.mcw.edu
SUMMARY:CRISPR MEDiCiNE 2025
DESCRIPTION:Meet the global CRISPR Medicine community at the second CRISPR MEDiCiNE conference. The focus will be on tools\, delivery\, safety/off-target\, diseases\, pre-clinical/clinical\, standards and regulations\, functional genomics\, target identification\, and target validation. \nApril 7-11th\, 2025; Copenhagen\, Denmark – Virtual event available April 7th \nLearn more at https://crisprmedicinenews.com/crisprmed/crisprmed25/
URL:https://scge.mcw.edu/events/crispr-medicine-2025/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/06/Screenshot-2024-06-12-102507.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20250408T190000
DTEND;TZID=America/Chicago:20250408T190000
DTSTAMP:20260418T091809
CREATED:20250311T151450Z
LAST-MODIFIED:20250311T151450Z
UID:4775-1744138800-1744138800@scge.mcw.edu
SUMMARY:Around the World: Frontline of AAV Vectors for Gene Therapy Research in Japan
DESCRIPTION:Explore cutting-edge advancements in the use of AAV vectors for gene therapy research in Japan. This event brings together leading scientists\, researchers\, and professionals in the field to discuss innovative approaches\, challenges\, and breakthroughs in gene delivery systems\, specifically focusing on AAV technology. \nVirtual \nRegister: https://www.asgct.org/asgct-events/april-2025/aav-vectors-gene-therapy-research-japan
URL:https://scge.mcw.edu/events/around-the-world-frontline-of-aav-vectors-for-gene-therapy-research-in-japan/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/06/Screenshot-2024-06-12-103632.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250409
DTEND;VALUE=DATE:20250412
DTSTAMP:20260418T091809
CREATED:20250128T160904Z
LAST-MODIFIED:20250128T160904Z
UID:4745-1744156800-1744415999@scge.mcw.edu
SUMMARY:Genomics of Rare Disease 2025
DESCRIPTION:The 2025 programme will highlight non-coding variants and the implication of rare disease on common diseases. Advances in therapeutics\, next-generation functional testing\, and the impact of genomics diagnostics and research on rare disease across the globe will also be showcased. \nUnited Kingdom (Virtual or In-person) \nhttps://coursesandconferences.wellcomeconnectingscience.org/event/genomics-of-rare-disease-20250409/
URL:https://scge.mcw.edu/events/genomics-of-rare-disease-2025/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2025/01/Screenshot-2025-01-28-100755.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250414
DTEND;VALUE=DATE:20250417
DTSTAMP:20260418T091809
CREATED:20240808T150133Z
LAST-MODIFIED:20240808T150133Z
UID:4377-1744588800-1744847999@scge.mcw.edu
SUMMARY:2nd International Conference on Human Genetics and Genetical Disorders
DESCRIPTION:Human Genetics and Genetical Disorders-2025 extend our immense pleasure and honor to invite you to attend the 2nd International Conference on Human Genetics and Genetical Disorders which is scheduled on April 14-16\, 2024 in Paris\, France. One of these directions was the need for genetic studies to identify genes and genetic markers of diagnostic\, prognostic and therapeutic value Genetic processes work in combination with an organism’s environment and experiences to influence development and behavior often referred to as nature versus nurture. \nParis\, France \nLearn more at https://geneticsresearch.net/
URL:https://scge.mcw.edu/events/2nd-international-conference-on-human-genetics-and-genetical-disorders/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/08/Screenshot-2024-08-08-100056.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250506
DTEND;VALUE=DATE:20250510
DTSTAMP:20260418T091809
CREATED:20250507T141827Z
LAST-MODIFIED:20250507T141909Z
UID:4847-1746489600-1746835199@scge.mcw.edu
SUMMARY:ISCT 2025
DESCRIPTION:International Society of Cell & Gene Therapy 2025 Annual Meeting \nNew Orleans\, LA \nhttps://www.isctglobal.org/annual-meeting/homepage
URL:https://scge.mcw.edu/events/isct-2025/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2025/05/Screenshot-2025-05-07-091803.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250513
DTEND;VALUE=DATE:20250518
DTSTAMP:20260418T091809
CREATED:20240612T153654Z
LAST-MODIFIED:20240612T153654Z
UID:4277-1747094400-1747526399@scge.mcw.edu
SUMMARY:ASGCT 2025
DESCRIPTION:Stay tuned for more information on ASGCT’s 2025 annual meeting. \nNew Orleans\, LA
URL:https://scge.mcw.edu/events/asgct-2025/
LOCATION:NH
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/06/Screenshot-2024-06-12-103632.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250521
DTEND;VALUE=DATE:20250524
DTSTAMP:20260418T091809
CREATED:20250520T200505Z
LAST-MODIFIED:20250520T200505Z
UID:4879-1747785600-1748044799@scge.mcw.edu
SUMMARY:Global Observatory for Genome Editing International Summit
DESCRIPTION:The Global Observatory’s 2025 Summit foregrounds questions about biotechnologies that may alter the meaning of being human. Genome editing\, especially of the human germline\, raises fundamental questions of the dignity and integrity of human life. Governance concerns once focused on the escape of potentially risky lab-created organisms. Today the more urgent concerns relate to transgressing moral boundaries and violating human integrity. How should the scientific community respond? \n\nVirtual or In-person in Cambridge\, MA \n\n\n\n\nhttps://www.summit.global-observatory.org/
URL:https://scge.mcw.edu/events/global-observatory-for-genome-editing-international-summit/
LOCATION:NH
ATTACH;FMTTYPE=image/jpeg:https://scge.mcw.edu/wp-content/uploads/2025/05/Global-Observatory-for-Genome-Editing-e1747771499432.jpg
END:VEVENT
END:VCALENDAR